60mg of tirzepatide – 60 mg Vial The Enigma of the 60mg
Description
Use of dapagliflozin 10 mg for glycemic control in patients without established CV disease or CV risk factors is not recommended when eGFR is less than 45 mL/min/1.73 m [see DOSAGE AND ADMINISTRATION ]
However, with a little preparation, you can keep your treatment on track
Whilst Liver physicians / hepatologists may be unfamiliar with using semaglutide, weight loss and better glycaemic control would be valuable for a substantial proportion of patients
doi:10.1038/s41586-020-2025-2
